OR WAIT 15 SECS
The Centers for Medicare & Medicaid Services issues a final rule clarifying its position on the inclusion of insulin and exclusion of erectile dysfunction medications in the Medicare Part D program.
The Centers for Medicare & Medicaid Services has issued a final rule clarifying its policies for the Medicare Part D program. According to the rule, devices for the inhalation of insulin will now be included in the program. In addition, any drug when used for the treatment of sexual or erectile dysfunction is excluded from the program. Among other changes the rule also ensures payment for administration of covered vaccines. The final rule was published in the April 15 Federal Register.